During the past decade, CCOP - MainLine Health conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 35 clinical trials were completed, i.e. on average, 1166.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 6 clinical trials were completed. i.e. 600% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CCOP - MainLine Health" #1 sponsor was "Radiation Therapy Oncology Group" with 45 trials, followed by "Eastern Cooperative Oncology Group" with 38 trials sponsored, "NSABP Foundation Inc" with 15 trials sponsored, "National Cancer Institute (NCI)" with 13 trials sponsored and "Alliance for Clinical Trials in Oncology" with 13 trials sponsored. Other sponsors include 26 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CCOP - MainLine Health" #1 collaborator was "National Cancer Institute (NCI)" with 134 trials as a collaborator, "NRG Oncology" with 16 trials as a collaborator, "Eastern Cooperative Oncology Group" with 10 trials as a collaborator, "NCIC Clinical Trials Group" with 7 trials as a collaborator and "SWOG Cancer Research Network" with 7 trials as a collaborator. Other collaborators include 25 different institutions and companies that were collaborators in the rest 22 trials.

According to Clinical.Site data, the most researched conditions in "CCOP - MainLine Health" are "Breast Cancer" (25 trials), "Lung Cancer" (18 trials), "Prostate Cancer" (18 trials), "Colorectal Cancer" (11 trials) and "Head and Neck Cancer" (11 trials). Many other conditions were trialed in "CCOP - MainLine Health" in a lesser frequency.

Most popular intervention types in "CCOP - MainLine Health" are "Drug" (123 trials), "Radiation" (50 trials), "Biological" (33 trials), "Procedure" (31 trials) and "Other" (17 trials). Other intervention types were less common.

The name of intervention was led by "radiation therapy" (29 trials), "paclitaxel" (20 trials), "cisplatin" (18 trials), "fluorouracil" (15 trials) and "Placebo" (10 trials). Other intervention names were less common.

The vast majority of trials in "CCOP - MainLine Health" are 99 trials for "All" genders, 37 trials for "Female" genders and 18 trials for "Male" genders.

Currently, there are NaN active trials in "CCOP - MainLine Health". undefined are not yet recruiting, 1 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 127 completed trials in CCOP - MainLine Health, undefined suspended trials, and 15 terminated clinical trials to date.

Out of the total trials that were conducted in CCOP - MainLine Health, 6 "Phase 1" clinical trials were conducted, 65 "Phase 2" clinical trials and 74 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 6 trials that are defined as “Not Applicable".